Phase II Clinical Experience With the Novel Proteasome Inhibitor Bortezomib in Patients With Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma von O'CONNOR, Owen A, WRIGHT, John, DUMETRESCU, Otila, ESSELTINE, Dixie, TREHU, Elizabeth, ADAMS, Julian, SCHENKEIN, David, ZELENETZ, Andrew D, MOSKOWITZ, Craig, MUZZY, Jamie, MACGREGOR-CORTELLI, Barbara, STUBBLEFIELD, Michael, STRAUS, David, PORTLOCK, Carol, HAMLIN, Paul, CHOI, Elizabeth

Volltext

Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier‐type 1, produces marked complete and durable remissions in a diversity of chemotherapy refr... von O'Connor, Owen A., Hamlin, Paul A., Portlock, Carol, Moskowitz, Craig H., Noy, Ariela, Straus, David J., MacGregor‐Cortelli, Barbara, Neylon, Ellen, Sarasohn, Debra, Dumetrescu, Otila, Mould, Diane R., Fleischer, Martin, Zelenetz, Andrew D., Sirotnak, Frank, Horwitz, Steven

Volltext

A multicentre phase II clinical experience with the novel aza‐epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non‐Hodgkin lymphoma and mantle ce... von O’Connor, Owen A., Portlock, Carol, Moskowitz, Craig, Straus, David, Hamlin, Paul, Stubblefield, Michael, Dumetrescu, Otila, Colevas, A. Dimitrios, Grant, Barbara, Zelenetz, Andrew

Volltext